Sprague Suzanne 4
4 · CME GROUP INC. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
CME Group COO Suzanne Sprague Receives 5,504-Share Award
What Happened
Suzanne Sprague, COO & Global Head of Clearing at CME Group (CME), received a performance-based award of 5,504 shares on 2026-03-15 at an imputed price of $311.40 per share (value ≈ $1,713,946). To satisfy tax-withholding obligations, she surrendered 2,439 shares (≈ $759,505) and an additional 76 shares (≈ $23,666), a total of 2,515 shares surrendered (≈ $783,171). Net shares delivered to Ms. Sprague from this vesting event were 2,989 shares.
Key Details
- Transaction date(s): 2026-03-15 (filed on 2026-03-17) — filing appears within the standard two-business-day Form 4 window.
- Award: 5,504 shares granted/acquired at $311.40 per share (total ≈ $1,713,946). (Code A = Award/Grant)
- Withholding disposals: 2,439 shares and 76 shares surrendered at $311.40 per share (total surrendered ≈ $783,171). (Code F = Tax withholding)
- Net shares retained from this vesting: 2,989 shares.
- Footnotes: F1 — vesting of 2022 performance shares under CME’s Omnibus Stock Plan, payout based on three‑year TSR vs. S&P 500 (1/1/2023–12/31/2025). F2/F3 — shares surrendered to the company to satisfy tax withholding on the performance award and on restricted stock vesting.
Context
This was a compensation-related vesting event (not an open-market purchase or sale). Awards and routine tax-withholding surrenders are common executive compensation mechanics and do not necessarily signal the insider’s trading view. Transaction codes: A = award/grant (acquisition), F = surrender/disposition to cover taxes.
Insider Transaction Report
- Award
Common Stock Class A
[F1]2026-03-15$311.40/sh+5,504$1,713,946→ 16,351 total - Tax Payment
Common Stock Class A
[F2]2026-03-15$311.40/sh−2,439$759,505→ 13,912 total - Tax Payment
Common Stock Class A
[F3]2026-03-15$311.40/sh−76$23,666→ 13,836 total
Footnotes (3)
- [F1]Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
- [F2]Ms. Sprague surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.
- [F3]Ms. Sprague surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026.